EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 79 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,430,860 | -60.0% | 947,794 | -46.0% | 0.00% | -66.7% |
| Q2 2023 | $13,592,330 | +170.2% | 1,753,849 | +132.6% | 0.00% | +200.0% |
| Q1 2023 | $5,030,107 | -47.2% | 754,139 | -29.2% | 0.00% | -50.0% |
| Q4 2022 | $9,522,182 | +1445.8% | 1,065,121 | +1601.4% | 0.00% | – |
| Q3 2022 | $616,000 | -46.9% | 62,601 | -57.1% | 0.00% | – |
| Q2 2022 | $1,161,000 | -9.4% | 145,815 | +10.3% | 0.00% | – |
| Q1 2022 | $1,282,000 | +107.1% | 132,166 | +226.2% | 0.00% | – |
| Q4 2021 | $619,000 | -70.8% | 40,512 | -37.9% | 0.00% | -100.0% |
| Q1 2021 | $2,121,000 | – | 65,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |